Gtcr LLC Maravai Lifesciences Holdings, Inc. Transaction History

Gtcr LLC

$1.28 Trillion
Q3 2024

A detailed history of Gtcr LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Gtcr LLC holds 20,150,005 shares of MRVI stock, worth $117 Million. This represents 13.05% of its overall portfolio holdings.

Number of Shares

20,150,005

Holding current value

$117 Million

% of portfolio

13.05%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.84 - $9.73 $138 Million - $196 Million	20,150,005 New	20,150,005 $167 Billion
Q2 2024 Aug 09, 2024	SELL	$6.87 - $11.34 $10.5 Million - $17.4 Million	-1,531,028 Reduced 7.06%	20,150,005 $144 Million
Q3 2021 Nov 01, 2021	SELL	$36.8 - $60.62 $108 Million - $178 Million	-2,931,441 Reduced 11.91%	21,681,033 $1.06 Billion
Q2 2021 Aug 05, 2021	SELL	$32.46 - $45.0 $98.5 Million - $137 Million	-3,034,041 Reduced 10.97%	24,612,474 $1.03 Billion
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $677 Million - $853 Million	27,646,515 New	27,646,515 $775 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

12 West Capital Management LP New York, NY

14M
Shares

$81.4 Million
12.14% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$69 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.73M
Shares

$56.5 Million
0.0% of portfolio
Braidwell LP Stamford, CT

8.35M
Shares

$48.5 Million
1.97% of portfolio
Mackenzie Financial Corp Toronto Ontario, A6

6.36M
Shares

$37 Million
0.08% of portfolio

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $764M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gtcr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gtcr LLC with notifications on news.

Account